Clorox Co.
The Clorox Company manufactures and markets consumer and professional products worldwide. The company operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers home care cleaning and disinfecting products, bleach, clog removers, and laundry additives under the Clorox, Clorox2, Pine-Sol, Scentiva, Tilex, Liquid-Plumr, Poett… Read more
Clorox Co. (0I0J) - Net Assets
Latest net assets as of December 2025: $35.00 Million USD
Based on the latest financial reports, Clorox Co. (0I0J) has net assets worth $35.00 Million USD as of December 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($5.61 Billion) and total liabilities ($5.58 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $35.00 Million |
| % of Total Assets | 0.62% |
| Annual Growth Rate | -0.34% |
| 5-Year Change | -18.58% |
| 10-Year Change | 62.29% |
| Growth Volatility | 78.43 |
Clorox Co. - Net Assets Trend (1986–2025)
This chart illustrates how Clorox Co.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Clorox Co. (1986–2025)
The table below shows the annual net assets of Clorox Co. from 1986 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-06-30 | $482.00 Million | -2.03% |
| 2024-06-30 | $492.00 Million | +26.80% |
| 2023-06-30 | $388.00 Million | -46.78% |
| 2022-06-30 | $729.00 Million | +23.14% |
| 2021-06-30 | $592.00 Million | -34.80% |
| 2020-06-30 | $908.00 Million | +62.43% |
| 2019-06-30 | $559.00 Million | -23.00% |
| 2018-06-30 | $726.00 Million | +33.95% |
| 2017-06-30 | $542.00 Million | +82.49% |
| 2016-06-30 | $297.00 Million | +151.69% |
| 2015-06-30 | $118.00 Million | -23.38% |
| 2014-06-30 | $154.00 Million | +5.48% |
| 2013-06-30 | $146.00 Million | +208.15% |
| 2012-06-30 | $-135.00 Million | -56.98% |
| 2011-06-30 | $-86.00 Million | -203.61% |
| 2010-06-30 | $83.00 Million | +147.43% |
| 2009-06-30 | $-175.00 Million | +52.70% |
| 2008-06-30 | $-370.00 Million | -316.37% |
| 2007-06-30 | $171.00 Million | +209.62% |
| 2006-06-30 | $-156.00 Million | +71.79% |
| 2005-06-30 | $-553.00 Million | -135.91% |
| 2004-06-30 | $1.54 Billion | +26.75% |
| 2003-06-30 | $1.22 Billion | -10.27% |
| 2002-06-30 | $1.35 Billion | -28.74% |
| 2001-06-30 | $1.90 Billion | +5.91% |
| 2000-06-30 | $1.79 Billion | +14.27% |
| 1999-06-30 | $1.57 Billion | +44.67% |
| 1998-06-30 | $1.09 Billion | +4.75% |
| 1997-06-30 | $1.04 Billion | +11.06% |
| 1996-06-30 | $932.80 Million | -1.18% |
| 1995-06-30 | $943.90 Million | +3.79% |
| 1994-06-30 | $909.40 Million | +3.42% |
| 1993-06-30 | $879.30 Million | +8.06% |
| 1992-06-30 | $813.70 Million | +3.75% |
| 1991-06-30 | $784.30 Million | -3.23% |
| 1990-06-30 | $810.50 Million | +3.09% |
| 1989-06-30 | $786.20 Million | +10.28% |
| 1988-06-30 | $712.90 Million | +15.66% |
| 1987-06-30 | $616.40 Million | +12.11% |
| 1986-06-30 | $549.80 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Clorox Co.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 1.8% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (June 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $432.00 Million | 134.58% |
| Common Stock | $131.00 Million | 40.81% |
| Other Comprehensive Income | $-157.00 Million | -48.91% |
| Total Equity | $321.00 Million | 100.00% |
Clorox Co. Competitors by Market Cap
The table below lists competitors of Clorox Co. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Somnigroup International Inc.
NYSE:SGI
|
$13.58 Billion |
|
WuXi Biologics
PINK:WXIBF
|
$13.58 Billion |
|
Valley National Bancorp 8.250% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock, Series C
PINK:VLYPN
|
$13.58 Billion |
|
Thomson Reuters Corporation Common Shares
NASDAQ:TRI
|
$13.62 Billion |
|
Logitech International SA
NASDAQ:LOGI
|
$13.54 Billion |
|
Coal India Limited
NSE:COALINDIA
|
$13.53 Billion |
|
AXIA Energia
NYSE:AXIA
|
$13.50 Billion |
|
Prysmian S.p.A
PINK:PRYMF
|
$13.49 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Clorox Co.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 328,000,000 to 321,000,000, a change of -7,000,000 (-2.1%).
- Net income of 810,000,000 contributed positively to equity growth.
- Dividend payments of 602,000,000 reduced retained earnings.
- Share repurchases of 332,000,000 reduced equity.
- Other comprehensive income decreased equity by 2,000,000.
- Other factors increased equity by 119,000,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $810.00 Million | +252.34% |
| Dividends Paid | $602.00 Million | -187.54% |
| Share Repurchases | $332.00 Million | -103.43% |
| Other Comprehensive Income | $-2.00 Million | -0.62% |
| Other Changes | $119.00 Million | +37.07% |
| Total Change | $- | -2.13% |
Book Value vs Market Value Analysis
This analysis compares Clorox Co.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 43.55x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 43.65x to 43.55x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1986-06-30 | $2.58 | $112.48 | x |
| 1987-06-30 | $2.88 | $112.48 | x |
| 1988-06-30 | $3.30 | $112.48 | x |
| 1989-06-30 | $3.55 | $112.48 | x |
| 1990-06-30 | $3.75 | $112.48 | x |
| 1991-06-30 | $3.62 | $112.48 | x |
| 1992-06-30 | $3.73 | $112.48 | x |
| 1993-06-30 | $4.01 | $112.48 | x |
| 1994-06-30 | $4.23 | $112.48 | x |
| 1995-06-30 | $4.48 | $112.48 | x |
| 1996-06-30 | $4.51 | $112.48 | x |
| 1997-06-30 | $4.92 | $112.48 | x |
| 1998-06-30 | $5.23 | $112.48 | x |
| 1999-06-30 | $6.54 | $112.48 | x |
| 2000-06-30 | $7.49 | $112.48 | x |
| 2001-06-30 | $7.93 | $112.48 | x |
| 2002-06-30 | $5.77 | $112.48 | x |
| 2003-06-30 | $5.51 | $112.48 | x |
| 2004-06-30 | $7.18 | $112.48 | x |
| 2005-06-30 | $-3.09 | $112.48 | x |
| 2006-06-30 | $-1.02 | $112.48 | x |
| 2007-06-30 | $1.11 | $112.48 | x |
| 2008-06-30 | $-2.61 | $112.48 | x |
| 2009-06-30 | $-1.24 | $112.48 | x |
| 2010-06-30 | $0.59 | $112.48 | x |
| 2011-06-30 | $-0.62 | $112.48 | x |
| 2012-06-30 | $-1.02 | $112.48 | x |
| 2013-06-30 | $1.10 | $112.48 | x |
| 2014-06-30 | $1.17 | $112.48 | x |
| 2015-06-30 | $0.89 | $112.48 | x |
| 2016-06-30 | $2.25 | $112.48 | x |
| 2017-06-30 | $4.12 | $112.48 | x |
| 2018-06-30 | $5.52 | $112.48 | x |
| 2019-06-30 | $4.31 | $112.48 | x |
| 2020-06-30 | $7.11 | $112.48 | x |
| 2021-06-30 | $3.23 | $112.48 | x |
| 2022-06-30 | $4.49 | $112.48 | x |
| 2023-06-30 | $1.77 | $112.48 | x |
| 2024-06-30 | $2.63 | $112.48 | x |
| 2025-06-30 | $2.58 | $112.48 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Clorox Co. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 252.34%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 11.40%
- • Asset Turnover: 1.28x
- • Equity Multiplier: 17.32x
- Recent ROE (252.34%) is above the historical average (101.16%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1986 | 17.39% | 8.78% | 1.28x | 1.54x | $40.62 Million |
| 1987 | 17.02% | 9.32% | 1.21x | 1.51x | $43.26 Million |
| 1988 | 18.60% | 10.52% | 1.09x | 1.62x | $61.31 Million |
| 1989 | 15.80% | 9.16% | 1.12x | 1.54x | $45.58 Million |
| 1990 | 18.95% | 10.35% | 1.30x | 1.40x | $72.55 Million |
| 1991 | 6.72% | 3.20% | 1.03x | 2.04x | $-25.73 Million |
| 1992 | 12.13% | 5.75% | 1.06x | 1.98x | $17.33 Million |
| 1993 | 18.99% | 10.22% | 0.99x | 1.88x | $79.07 Million |
| 1994 | 23.32% | 11.55% | 1.08x | 1.87x | $121.16 Million |
| 1995 | 21.27% | 10.12% | 1.04x | 2.02x | $106.41 Million |
| 1996 | 23.81% | 10.01% | 1.02x | 2.34x | $128.82 Million |
| 1997 | 28.96% | 11.85% | 0.91x | 2.68x | $196.40 Million |
| 1998 | 31.61% | 12.51% | 0.90x | 2.79x | $234.48 Million |
| 1999 | 15.67% | 6.15% | 0.97x | 2.63x | $89.00 Million |
| 2000 | 21.96% | 9.65% | 0.94x | 2.43x | $214.60 Million |
| 2001 | 17.00% | 8.28% | 0.98x | 2.10x | $133.00 Million |
| 2002 | 23.78% | 7.93% | 1.12x | 2.68x | $186.60 Million |
| 2003 | 40.58% | 11.90% | 1.13x | 3.01x | $371.50 Million |
| 2004 | 35.65% | 12.70% | 1.13x | 2.49x | $395.00 Million |
| 2005 | 0.00% | 24.98% | 1.21x | 0.00x | $1.15 Billion |
| 2006 | 0.00% | 9.56% | 1.28x | 0.00x | $459.60 Million |
| 2007 | 292.98% | 10.34% | 1.32x | 21.44x | $483.90 Million |
| 2008 | 0.00% | 8.74% | 1.12x | 0.00x | $498.00 Million |
| 2009 | 0.00% | 9.85% | 1.19x | 0.00x | $554.50 Million |
| 2010 | 726.51% | 11.52% | 1.15x | 54.88x | $594.70 Million |
| 2011 | 0.00% | 10.65% | 1.26x | 0.00x | $565.60 Million |
| 2012 | 0.00% | 9.89% | 1.26x | 0.00x | $554.50 Million |
| 2013 | 391.78% | 10.17% | 1.30x | 29.53x | $557.40 Million |
| 2014 | 362.34% | 10.12% | 1.29x | 27.65x | $542.60 Million |
| 2015 | 491.53% | 10.26% | 1.36x | 35.29x | $568.20 Million |
| 2016 | 218.18% | 11.25% | 1.28x | 15.21x | $618.30 Million |
| 2017 | 129.34% | 11.74% | 1.31x | 8.44x | $646.80 Million |
| 2018 | 113.36% | 13.44% | 1.21x | 6.97x | $750.40 Million |
| 2019 | 146.69% | 13.20% | 1.21x | 9.15x | $764.10 Million |
| 2020 | 103.41% | 13.97% | 1.08x | 6.84x | $848.20 Million |
| 2021 | 172.75% | 9.67% | 1.16x | 15.41x | $668.90 Million |
| 2022 | 83.09% | 6.50% | 1.15x | 11.08x | $406.40 Million |
| 2023 | 67.73% | 2.02% | 1.24x | 27.02x | $127.00 Million |
| 2024 | 85.37% | 3.95% | 1.23x | 17.53x | $247.20 Million |
| 2025 | 252.34% | 11.40% | 1.28x | 17.32x | $777.90 Million |
Industry Comparison
This section compares Clorox Co.'s net assets metrics with peer companies in the same industry.
Industry Context
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Clorox Co. (0I0J) | $35.00 Million | 17.39% | 159.37x | $13.55 Billion |
| Nyfosa AB (0A0K) | $2.92 Billion | 39.50% | 2.88x | $973.31 Million |
| High Templar Tech Limited (0A2T) | $12.52 Billion | 4.70% | 0.13x | $255.82 Million |
| Strategy Inc (0A7O) | $51.04 Billion | -7.54% | 0.21x | $40.17 Billion |
| NACON SASU (0A9N) | $67.54 Million | 15.85% | 1.20x | $7.64 Million |
| Antin Infrastructure Partners (0AA5) | $23.79 Million | 108.98% | 1.09x | $573.10 Million |
| Truecaller AB Series B (0AA7) | $1.41 Billion | 18.30% | 0.20x | $281.60 Million |
| Brockhaus Technologies AG (0AAW) | $254.92 Million | -6.23% | 1.68x | $74.40 Million |
| Hyloris Pharmaceuticals S.A. (0AB6) | $48.06 Million | -24.09% | 0.32x | $71.96 Million |
| Kalray S.A. (0ABT) | $28.43 Million | -41.56% | 0.67x | $33.84 Million |
| Webuild S.p.A. (0BJP) | $1.43 Billion | 10.29% | 7.14x | $1.13 Billion |